One unifying element of this program project is the use of Mycoplasma pulmonis-infected mice and rats as a model of chronic airway inflammation. All four projects will use this model to different extents in the proposed research. A small animal core will be established to serve two main functions: (i) to standardize M. pulmonis infection procedures and the handling of pathogen-free and infected mice and rats; and (ii) to develop, optimize and implement genotyping procedures to identify mutant mice. The core staff will establish virulent stocks of M. pulmonis. These stocks will be tested and used in all future experiments for program investigators in order to ensure reproducible results and to minimize variability. The core staff will be responsible for monitoring of pathogen-free and infected animals in the barrier facility, including the routine measurement of body weight, and periodic serological analyses. The core staff will also assist with some aspects of tissue harvesting, for example, bronchoalveolar lavage, flow cytometry, and tissue removal and fixation. Lastly, the core will use standardized flow cytometric, DNA preparation and polymerase chain reaction procedures to genotype mice from the various mutant colonies that will be used in the four projects. Centralizing infection and genotyping procedures will avoid unnecessary replication of resources in the four projects. It will also ensure that common procedures are used by all of the groups and will, therefore, facilitate the exchange of information and foster collaborative interactions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL024136-26
Application #
6955304
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
26
Fiscal Year
2004
Total Cost
$151,199
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ma, Qiaoli; Dieterich, Lothar C; Ikenberg, Kristian et al. (2018) Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread. Sci Adv 4:eaat4758
Kim, Minah; Nitschké, Maximilian; Sennino, Barbara et al. (2018) Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms. Cancer Res 78:922-937
Nitschké, Maximilian; Bell, Alexander; Karaman, Sinem et al. (2017) Retrograde Lymph Flow Leads to Chylothorax in Transgenic Mice with Lymphatic Malformations. Am J Pathol 187:1984-1997
Shepherd, Joanna; Fisher, Matthew; Welford, Abigail et al. (2017) The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-O-phosphate. Oncotarget 8:95648-95661
Baluk, Peter; Yao, Li-Chin; Flores, Julio C et al. (2017) Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract. JCI Insight 2:
Caughey, George H (2016) Mast cell proteases as pharmacological targets. Eur J Pharmacol 778:44-55
Korhonen, Emilia A; Lampinen, Anita; Giri, Hemant et al. (2016) Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest 126:3495-510
Kim, Minah; Allen, Breanna; Korhonen, Emilia A et al. (2016) Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation. J Clin Invest 126:3511-25
Headley, Mark B; Bins, Adriaan; Nip, Alyssa et al. (2016) Visualization of immediate immune responses to pioneer metastatic cells in the lung. Nature 531:513-7
Pinkard, Henry; Stuurman, Nico; Corbin, Kaitlin et al. (2016) Micro-Magellan: open-source, sample-adaptive, acquisition software for optical microscopy. Nat Methods 13:807-809

Showing the most recent 10 out of 593 publications